Soligenix IncSNGX
Price$0.36

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $119.4K0.0% YoYTTM through 30 Jun 2026
Net Income -$11.1MTTM through 30 Jun 2026
Free Cash Flow -$9.7MTTM through 30 Jun 2026

Margins

Current
Gross Margin0.0%
Operating Margin-9,923.2%
Net Margin-9,282.3%

Returns

-354.4%ROE
-158.2%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio1.81x
Net Debt-$6Mnet cash position
Cash & Equivalents$9.8M

Quality Metrics

Altman Z-Score-34.98
Piotroski F-Score3 / 9
FCF Margin-8,166.2%
Earnings-Beat Rate33.3%

Multi-Year Trend

Revenue
'18'19'20'21'22'23'24
FY2024: $119.4K
Diluted EPS-$0.72TTM
'17'20'21'22'23'24'25
FY2025: $-2.14

Dividend

No dividend

Capital Allocation

R&D Spend$6.6M
Capex Intensity4.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.